ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166237; 2) Community: the network communities that were significantly associated with the response to NSC 166237; 3) Molecule: the relationships between components within communities and NSC 166237; 4) MDR: the compounds that were significantly associated with the NSC 166237.

NSC Compound Enrichment Correlation
NSC 730690 Null 0.00248478006478608 -0.30057109
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.00248478006478608 -0.17517617
NSC 300289 Pinafide 0.00248668807445192 0.49689436
NSC 603071 Aminocamptothecin 0.00248668807445192 0.52347346
NSC 615291 Bizelesin 0.00248668807445192 0.56569
NSC 642324 Null 0.00248668807445192 0.46507842
NSC 672974 Null 0.00248668807445192 0.40613963
NSC 681641 Camptothecin Derivative 0.00248668807445192 0.52343323
NSC 740033 9-Amino-6-(3-azidopropyl)-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline 0.00248668807445192 0.54743414
NSC 746930 Null 0.00248668807445192 0.13242511
Total:64  Current:7    [First] [Prev] [Next] [Last]